The number of insider buy/sell trades at Fate Therapeutics is greater than the 324 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 454 buy/sell trades during this period for an average of 1.4 transactions per company. The number of shares per buy/sell trade for Fate Therapeutics insiders was also higher. Within the peer group there were 121,212,090 shares purchased and 16,629,905 shares sold with company insiders purchasing 399,169 shares on average.
For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data sourced to compose and write this story.
|Sabre Plans to Challenge Justice Department Lawsuit ...|
|First Merchants Revises Record Date for Quarterly Di...|
|US TREASURIES: Bond Prices Aiming Higher After Stint...|
|Stock Move: Kohl's Drops 6% as Fiscal Q2 Gross Margi...|
|Street Color: US Treasuries Levels|